CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator.
Moon YW, An HJ, Koo JS, Kim GM, Han H, Park S, Kim SI, Park HS, Kim S, Kim SK, Lee SA, Hwang S, Son GW, Sohn J.
Moon YW, et al. Among authors: kim gm, kim si, kim s, kim sk.
Oncotarget. 2017 Dec 21;9(2):2622-2630. doi: 10.18632/oncotarget.23519. eCollection 2018 Jan 5.
Oncotarget. 2017.
PMID: 29416796
Free PMC article.